The Antibiotic Kitasamycin—A Potential Agent for Specific Fibrosis Preventing Therapy after Fistulating Glaucoma Surgery?

One major complication after fistulating glaucoma surgeries are fibroblast-mediated scarring processes and their specific prevention is key in the development of novel pharmaceutical concepts. Within this study a possible antifibrotic potential of kitasamycin (KM) in a transforming growth factor (TG...

Descripción completa

Detalles Bibliográficos
Autores principales: Sterenczak, Katharina A., Fuellen, Georg, Jünemann, Anselm, Guthoff, Rudolf F., Stachs, Oliver, Stahnke, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960401/
https://www.ncbi.nlm.nih.gov/pubmed/36839651
http://dx.doi.org/10.3390/pharmaceutics15020329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960401/
https://www.ncbi.nlm.nih.gov/pubmed/36839651
http://dx.doi.org/10.3390/pharmaceutics15020329

Ejemplares similares